Exciting news for the healthcare community! The European Medicines Agency has just approved the continent’s first AI-powered early detection tool designed specifically for pediatric rare diseases. This innovative platform leverages advanced machine learning to analyze electronic health records and genetic data, allowing clinicians to identify signs of rare conditions in children at an unprecedented early stage. This breakthrough promises to reduce diagnostic odysseys, facilitate timely interventions, and improve outcomes for young patients. What do you think about AI’s growing role in rare disease detection?